FDA Approval for Moderna's mNexspike COVID Vaccine

Moderna’s new COVID-19 vaccine, mNexspike, has received FDA approval, but there are restrictions on its usage. A directive from Kennedy highlighted concerns about the vaccine’s risks for healthy children and pregnant women due to insufficient safety data and uncertain benefits for this demographic. Despite FDA approval, limitations exist for certain groups, indicating a cautious approach to widespread use.